March is an exciting month for colleges. The captivating national basketball tournaments are in full swing, students get to enjoy spring break, and long-lost academicians emerge from winter hibernation. And, if you happen to study at Boston University, you can follow along as your school has assumed a plaintiff’s role in a patent infringement lawsuit. Read more about Patent Wednesday: The Ole College Try[…]
One of the more common drugs featured in recent television advertisements is Celebrex®, a painkiller manufactured by pharmaceutical giant Pfizer®. Holding a patent on Celebrex® allows Pfizer® to exclusively make, use, sell, or offer to sell the drug. The United States Patent and Trademark Office (USPTO) granted Pfizer® a “reissue” patent on the active ingredient Read more about Patent Wednesday: Pfizer® Takes a Hit[…]
If you own a patent, you enjoy the exclusive rights to make, use, sell, and offer for sale the underlying invention covered by that patent. Imagine if you own a patent and you decide to license the use of it to another entity. Then, the licensing entity embarks on an allegedly infringing activity. Whose burden Read more about Patent Wednesday: Revisiting Medtronic[…]
Whether you’re in the market for legal representation or car repair, one of the most important questions is how to minimize costs associated with services. In the United States, it’s typical for each litigating party to pay its own attorney fees no matter the outcome. But is it possible that one party could ever be Read more about Patent Wednesday: Who Pays the Bill?[…]